[1] WIGINTON JG 4TH, BRAZDZIONIS J, MOHRDAR C, et al. Spinal Cord Reperfusion Injury: Case Report, Review of the Literature, and Future Treatment Strategies. Cureus. 2019;11(7): e5279.
[2] WANG HC, LIN YT, HSU SY, et al. Serial plasma DNA levels as predictors of outcome in patients with acute traumatic cervical spinal cord injury. J Transl Med. 2019;17(1):329.
[3] SCHWAB ME, BARTHOLDI D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev. 1996;76(2): 319-370.
[4] SILVER JR. A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord. 2011;49(3): 482; author reply 484.
[5] THURET S, MOON LD, GAGE FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci. 2006;7(8):628-643.
[6] REGAN MA, TEASELL RW, WOLFE DL, et al. A systematic review of therapeutic interventions for pressure ulcers after spinal cord injury. Arch Phys Med Rehabil. 2009;90(2):213-231.
[7] TEASELL RW, MEHTA S, AUBUT JL, et al. A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord. 2010;48(7):512-521.
[8] CHOO AM, LIU J, DVORAK M, et al. Secondary pathology following contusion, dislocation, and distraction spinal cord injuries. Exp Neurol. 2008;212(2):490-506.
[9] DONNELLY DJ, POPOVICH PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209(2):378-388.
[10] LIN XY, LAI BQ, ZENG X, et al. Cell Transplantation and Neuroengineering Approach for Spinal Cord Injury Treatment: A Summary of Current Laboratory Findings and Review of Literature. Cell Transplant. 2016;25(8):1425-1438.
[11] RIBEIRO-SAMY S, SILVA NA, CORRELO VM, et al. Development and characterization of a PHB-HV-based 3D scaffold for a tissue engineering and cell-therapy combinatorial approach for spinal cord injury regeneration. Macromol Biosci. 2013;13(11): 1576-1592.
[12] ERN C, FRASHERI I, BERGER T, et al. Effects of prostaglandin E2 and D2 on cell proliferation and osteogenic capacity of human mesenchymal stem cells. Prostaglandins Leukot Essent Fatty Acids. 2019;151:1-7.
[13] LI Z, YE H, CAI X, et al. Bone marrow-mesenchymal stem cells modulate microglial activation in the peri-infarct area in rats during the acute phase of stroke. Brain Res Bull. 2019;153:324-333.
[14] YANG C, LIM W, PARK J, et al. Anti-inflammatory effects of mesenchymal stem cell-derived exosomal microRNA-146a-5p and microRNA-548e-5p on human trophoblast cells. Mol Hum Reprod. 2019; 25(11):755-771.
[15] CHU KA, WANG SY, YEH CC, et al. Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly. Theranostics. 2019;9(22):6646-6664.
[16] CHEN Z, HAN X, OUYANG X, et al. Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury. Theranostics. 2019;9(22): 6354-6368.
[17] KOAYKUL C, KIM MH, KAWAHARA Y, et al. Maintenance of Neurogenic Differentiation Potential in Passaged Bone Marrow-Derived Human Mesenchymal Stem Cells Under Simulated Microgravity Conditions. Stem Cells Dev. 2019;28(23): 1552-1561.
[18] GEFFNER LF, SANTACRUZ P, IZURIETA M, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008;17(12): 1277-1293.
[19] OSAKA M, HONMOU O, MURAKAMI T, et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 2010;1343: 226-235.
[20] ANTONIC A, SENA ES, LEES JS, et al. Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol. 2013;11(12): e1001738.
[21] NAKAJIMA H, UCHIDA K, GUERRERO AR, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma. 2012;29(8):1614-1625.
[22] BARBIER L, RAMOS E, MENDIOLA J, et al. Autologous dental pulp mesenchymal stem cells for inferior third molar post-extraction socket healing: A split-mouth randomised clinical trial. Med Oral Patol Oral Cir Bucal. 2018;23(4):e469-e477.
[23] LEVI AD, ANDERSON KD, OKONKWO DO, et al. Clinical Outcomes from a Multi-Center Study of Human Neural Stem Cell Transplantation in Chronic Cervical Spinal Cord Injury. J Neurotrauma. 2019;36(6):891-902.
[24] NICODEMUS GD, BRYANT SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev. 2008;14(2):149-165.
[25] ZHOU X, SHI G, FAN B, et al. Polycaprolactone electrospun fiber scaffold loaded with iPSCs-NSCs and ASCs as a novel tissue engineering scaffold for the treatment of spinal cord injury. Int J Nanomedicine. 2018;13:6265-6277.
[26] JI WC, ZHANG XW, QIU YS. Selected suitable seed cell, scaffold and growth factor could maximize the repair effect using tissue engineering method in spinal cord injury. World J Exp Med. 2016;6(3):58-62.
[27] SILVA NA, SALGADO AJ, SOUSA RA, et al. Development and characterization of a novel hybrid tissue engineering-based scaffold for spinal cord injury repair. Tissue Eng Part A. 2010;16(1):45-54.
[28] MACAYA D, SPECTOR M. Injectable hydrogel materials for spinal cord regeneration: a review. Biomed Mater. 2012;7(1):012001.
[29] MORITA T, SASAKI M, KATAOKA-SASAKI Y, et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016;335:221-231.
[30] ZHOU HL, ZHANG XJ, ZHANG MY, et al. Transplantation of Human Amniotic Mesenchymal Stem Cells Promotes Functional Recovery in a Rat Model of Traumatic Spinal Cord Injury. Neurochem Res. 2016;41(10): 2708-2718.
[31] SATTI HS, WAHEED A, AHMED P, et al. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study. Cytotherapy. 2016;18(4):518-522.
[32] VOLPATO FZ, FÜHRMANN T, MIGLIARESI C, et al. Using extracellular matrix for regenerative medicine in the spinal cord. Biomaterials. 2013; 34(21):4945-4955.
[33] BOIDO M, GHIBAUDI M, GENTILE P, et al. Chitosan-based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment. Sci Rep. 2019;9(1):6402.
[34] HU X, ZHOU X, LI Y, et al. Application of stem cells and chitosan in the repair of spinal cord injury. Int J Dev Neurosci. 2019;76:80-85.
[35] CAI Z, GAN Y, BAO C, et al. Photosensitive Hydrogel Creates Favorable Biologic Niches to Promote Spinal Cord Injury Repair. Adv Healthc Mater. 2019;8(13):e1900013.
[36] MORENO PMD, RODRIGUES T, TORRADO M, et al. Delivery of Antisense Oligonucleotides Mediated by a Hydrogel System: In Vitro and In Vivo Application in the Context of Spinal Cord Injury. Methods Mol Biol. 2019;2036:205-219.
[37] ZAVISKOVA K, TUKMACHEV D, DUBISOVA J, et al. Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair. J Biomed Mater Res A. 2018; 106(4):1129-1140.
[38] SITOCI-FICICI KH, MATYASH M, UCKERMANN O, et al. Non-functionalized soft alginate hydrogel promotes locomotor recovery after spinal cord injury in a rat hemimyelonectomy model. Acta Neurochir (Wien). 2018;160(3):449-457.
[39] 王欢,林宏生,查振刚,等.聚左旋乳酸/壳聚糖纳米纤维三维多孔支架复合骨髓间充质干细胞修复兔骨缺损[J].中国组织工程研究, 2012,16(8):1331-1335.
[40] NGUYEN LH, GAO M, LIN J, et al. Author Correction: Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment. Sci Rep. 2018;8(1):13057.
[41] WANG YH, CHEN J, ZHOU J, et al. Reduced inflammatory cell recruitment and tissue damage in spinal cord injury by acellular spinal cord scaffold seeded with mesenchymal stem cells. Exp Ther Med. 2017; 13(1):203-207.
[42] ZHANG XY, XUE H, LIU JM, et al. Chemically extracted acellular muscle: a new potential scaffold for spinal cord injury repair. J Biomed Mater Res A. 2012;100(3):578-587.
[43] SUN Y, YANG C, ZHU X, et al. 3D printing collagen/chitosan scaffold ameliorated axon regeneration and neurological recovery after spinal cord injury. J Biomed Mater Res A. 2019;107(9): 1898-1908.
[44] 方洪松,周建林,彭昊,等.不同来源间充质干细胞生物学特性差异[J].中国组织工程研究, 2015,19(32):5243-5248.
[45] PASANISI E, CIAVARELLA C, VALENTE S, et al. Differentiation and plasticity of human vascular wall mesenchymal stem cells, dermal fibroblasts and myofibroblasts: a critical comparison including ultrastructural evaluation of osteogenic potential. Ultrastruct Pathol. 2019;43(6):261-272.
[46] TAGUCHI T, BORJESSON DL, OSMOND C, et al. Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells. Stem Cells Dev. 2019;28(23):1562-1571.
[47] ITOSAKA H, KURODA S, SHICHINOHE H, et al. Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering. Neuropathology. 2009;29(3):248-257.
[48] KIM JH, SHIM SR, DOO SW, et al. Bladder recovery by stem cell based cell therapy in the bladder dysfunction induced by spinal cord injury: systematic review and meta-analysis. PLoS One. 2015;10(3):e0113491.
[49] DU BL, ZENG X, MA YH, et al. Graft of the gelatin sponge scaffold containing genetically-modified neural stem cells promotes cell differentiation, axon regeneration, and functional recovery in rat with spinal cord transection. J Biomed Mater Res A. 2015;103(4): 1533-1545.
[50] WAGNER ER, BRAVO D, DADSETAN M, et al. Ligament Tissue Engineering Using a Novel Porous Polycaprolactone Fumarate Scaffold and Adipose Tissue-Derived Mesenchymal Stem Cells Grown in Platelet Lysate. Tissue Eng Part A. 2015;21(21-22):2703-2713.
[51] GAO S, ZHAO P, LIN C, et al. Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds. Tissue Eng Part A. 2014;20(7-8):1271-1284.
[52] CARON I, ROSSI F, PAPA S, et al. A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. Biomaterials. 2016;75:135-147.
[53] JIAO G, LOU G, MO Y, et al. A combination of GDNF and hUCMSC transplantation loaded on SF/AGs composite scaffolds for spinal cord injury repair. Mater Sci Eng C Mater Biol Appl. 2017;74:230-237.
[54] EBRAHIMI-BAROUGH S, NOROUZI JAVIDAN A, SABERI H, et al. Evaluation of Motor Neuron-Like Cell Differentiation of hEnSCs on Biodegradable PLGA Nanofiber Scaffolds. Mol Neurobiol. 2015;52(3): 1704-1713.
[55] YANG C, LI X, SUN L, et al. Potential of human dental stem cells in repairing the complete transection of rat spinal cord. J Neural Eng. 2017; 14(2):026005.
[56] ZHANG J, LU X, FENG G, et al. Chitosan scaffolds induce human dental pulp stem cells to neural differentiation: potential roles for spinal cord injury therapy. Cell Tissue Res. 2016;366(1):129-142.
[57] RAZAVI S, GHASEMI N, MARDANI M, et al. Remyelination improvement after neurotrophic factors secreting cells transplantation in rat spinal cord injury. Iran J Basic Med Sci. 2017;20(4):392-398.
[58] BROCK JH, ROSENZWEIG ES, BLESCH A, et al. Local and remote growth factor effects after primate spinal cord injury. J Neurosci. 2010; 30(29):9728-9737.
[59] MENEI P, MONTERO-MENEI C, WHITTEMORE SR, et al. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur J Neurosci. 1998;10(2):607-621.
[60] HAN S, WANG B, JIN W, et al. The collagen scaffold with collagen binding BDNF enhances functional recovery by facilitating peripheral nerve infiltrating and ingrowth in canine complete spinal cord transection. Spinal Cord. 2014;52(12):867-873.
[61] KADOYA S, NAKAMURA T, TAKARADA A, et al. Magnetic resonance imaging of diseased cervical and lumbar intervertebral discs. Neurol Med Chir (Tokyo). 1989;29(2):99-105.
[62] HWANG DH, KIM HM, KANG YM, et al. Combination of multifaceted strategies to maximize the therapeutic benefits of neural stem cell transplantation for spinal cord repair. Cell Transplant. 2011;20(9):1361-1379.
[63] NOVIKOVA LN, NOVIKOV LN, KELLERTH JO. Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci. 2000;12(2):776-780.
[64] BLESCH A, TUSZYNSKI MH. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J Comp Neurol. 2003;467(3):403-417.
[65] FENG SQ, KONG XH, LIU Y, et al. Regeneration of spinal cord with cell and gene therapy. Orthop Surg. 2009;1(2):153-163.
[66] GOLDSHMIT Y, FRISCA F, PINTO AR, et al. Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury. Brain Behav. 2014;4(2):187-200.
[67] LEE MJ, CHEN CJ, CHENG CH, et al. Combined treatment using peripheral nerve graft and FGF-1: changes to the glial environment and differential macrophage reaction in a complete transected spinal cord. Neurosci Lett. 2008;433(3):163-169.
[68] MARKMEE R, AUNGSUCHAWAN S, POTHACHAROEN P, et al. Effect of ascorbic acid on differentiation of human amniotic fluid mesenchymal stem cells into cardiomyocyte-like cells. Heliyon. 2019;5(7):e02018.
[69] MASSOTO TB, SANTOS ACR, RAMALHO BS, et al. Mesenchymal stem cells and treadmill training enhance function and promote tissue preservation after spinal cord injury. Brain Res. 2020;1726:146494.
[70] KUMAGAI G, TSOULFAS P, TOH S, et al. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol. 2013;248:369-380.
[71] HACEIN-BEY-ABINA S, VON KALLE C, SCHMIDT M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302(5644):415-419.
[72] LIMONGI T, ROCCHI A, CESCA F, et al. Delivery of Brain-Derived Neurotrophic Factor by 3D Biocompatible Polymeric Scaffolds for Neural Tissue Engineering and Neuronal Regeneration. Mol Neurobiol. 2018; 55(12):8788-8798.
[73] CHEHREHASA F, COBCROFT M, YOUNG YW, et al. An acute growth factor treatment that preserves function after spinal cord contusion injury. J Neurotrauma. 2014;31(21):1807-1813.
[74] GARCÍA-ALÍAS G, PETROSYAN HA, SCHNELL L, et al. Chondroitinase ABC combined with neurotrophin NT-3 secretion and NR2D expression promotes axonal plasticity and functional recovery in rats with lateral hemisection of the spinal cord. J Neurosci. 2011;31(49):17788-17799.
[75] KANNO H, PRESSMAN Y, MOODY A, et al. Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci. 2014;34(5):1838-1855.
[76] BOYCE VS, MENDELL LM. Neurotrophic factors in spinal cord injury. Handb Exp Pharmacol. 2014;220:443-460.
[77] LIU J, CHEN T, LEI P, et al. Exosomes Released by Bone Marrow Mesenchymal Stem Cells Attenuate Lung Injury Induced by Intestinal Ischemia Reperfusion via the TLR4/NF-κB Pathway. Int J Med Sci. 2019;16(9):1238-1244.
[78] BASTOS R, MATHIAS M, ANDRADE R, et al. Intra-articular injection of culture-expanded mesenchymal stem cells with or without addition of platelet-rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: a controlled, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc. 2019 Oct 5. doi: 10.1007/s00167-019-05732-8. [Epub ahead of print]
[79] MAFIKANDI V, ROODBARI NH, NABIUNI M, et al. Effects of maternal thyroid hormone deficiency on differentiation of mesenchymal stem cells in CSF-exposed neonatal Wistar rats. Acta Neurobiol Exp (Wars). 2019; 79(3):270-275.
|